Division of Translational Cancer Research
41 – 50 of 584
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer
(
- Contribution to journal › Article
-
Mark
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
(
- Contribution to journal › Article
-
Mark
Homocysteine accelerates hepatocyte autophagy by upregulating TFEB via DNMT3b-mediated DNA hypomethylation
(
- Contribution to journal › Article
-
Mark
KRAS G12C Mutant Non–Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis : Population-based Demographics and Survival Data From the National Swedish Lung Cancer Registry
(
- Contribution to journal › Article
-
Mark
Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations : The EAU-RF NIMBUS Trial
(
- Contribution to journal › Article
-
Mark
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer : A subgroup analysis of the randomised clinical TITAN study
(
- Contribution to journal › Article
-
Mark
Acoustophoresis enriches tumor cell clusters in blood of patients with prostate cancer
2023) Acoustofluidics Conference 2023, St. Louis USA(
- Contribution to conference › Abstract
-
Mark
Acoustophoresis enrichment of tumor cell clusters in blood of patients with metastatic prostate cancer
2023) The 27th International Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2023)(
- Contribution to conference › Abstract
-
Mark
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms
(
- Contribution to journal › Article
-
Mark
PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia
(
- Contribution to journal › Article